144 related articles for article (PubMed ID: 25753982)
1. Patients with Persistently Elevated PSA and Negative Results of TRUS-Biopsy: Does 6-Month Treatment with Dutasteride can Indicate Candidates for Re-Biopsy. What is the Best of Saturation Schemes: Transrectal or Transperineal Approach?
Kravchick S; Lobik L; Cytron S; Kravchenko Y; Dor DB; Peled R
Pathol Oncol Res; 2015 Sep; 21(4):985-9. PubMed ID: 25753982
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen increase during dutasteride to indicate the need for prostate biopsy: influence of prostatic inflammation.
Sciarra A; Maggi M; Fasulo A; Salciccia S; Gentile V; Cattarino S; Gentilucci A
Urologia; 2017 Aug; 84(3):158-164. PubMed ID: 28430341
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study.
Marberger M; Freedland SJ; Andriole GL; Emberton M; Pettaway C; Montorsi F; Teloken C; Rittmaster RS; Somerville MC; Castro R
BJU Int; 2012 Apr; 109(8):1162-9. PubMed ID: 21699645
[TBL] [Abstract][Full Text] [Related]
4. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies.
Gershman B; Zietman AL; Feldman AS; McDougal WS
Urol Oncol; 2013 Oct; 31(7):1093-7. PubMed ID: 22305626
[TBL] [Abstract][Full Text] [Related]
5. The Efficacy of Transrectal Ultrasound Guided Biopsy Versus Transperineal Template Biopsy of the Prostate in Diagnosing Prostate Cancer in Men with Previous Negative Transrectal Ultrasound Guided Biopsy.
Nafie S; Wanis M; Khan M
Urol J; 2017 Mar; 14(2):3008-3012. PubMed ID: 28299763
[TBL] [Abstract][Full Text] [Related]
6. The pursuit of prostate cancer in patients with a rising prostate-specific antigen and multiple negative transrectal ultrasound-guided prostate biopsies.
Pryor MB; Schellhammer PF
Clin Prostate Cancer; 2002 Dec; 1(3):172-6. PubMed ID: 15046692
[TBL] [Abstract][Full Text] [Related]
7. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy.
Mabjeesh NJ; Lidawi G; Chen J; German L; Matzkin H
BJU Int; 2012 Oct; 110(7):993-7. PubMed ID: 22394668
[TBL] [Abstract][Full Text] [Related]
8. Transperineal template prostate biopsies in men with raised PSA despite two previous sets of negative TRUS-guided prostate biopsies.
Nafie S; Pal RP; Dormer JP; Khan MA
World J Urol; 2014 Aug; 32(4):971-5. PubMed ID: 24337167
[TBL] [Abstract][Full Text] [Related]
9. [Comparison in the follow-up of two patients with persistent elevated PSA and negative prostate biopsy].
Sciarra A; Panebianco V
Urologia; 2014; 81(1):60-3. PubMed ID: 24585440
[TBL] [Abstract][Full Text] [Related]
10. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
Dimmen M; Vlatkovic L; Hole KH; Nesland JM; Brennhovd B; Axcrona K
BJU Int; 2012 Jul; 110(2 Pt 2):E69-75. PubMed ID: 22093091
[TBL] [Abstract][Full Text] [Related]
11. Detection rate and factors predictive the presence of prostate cancer in patients undergoing ultrasonography-guided transperineal saturation biopsies of the prostate.
Novara G; Boscolo-Berto R; Lamon C; Fracalanza S; Gardiman M; Artibani W; Ficarra V
BJU Int; 2010 May; 105(9):1242-6. PubMed ID: 19863531
[TBL] [Abstract][Full Text] [Related]
12. Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection.
Watanabe M; Hayashi T; Tsushima T; Irie S; Kaneshige T; Kumon H
Int J Urol; 2005 Nov; 12(11):959-63. PubMed ID: 16351651
[TBL] [Abstract][Full Text] [Related]
13. PI-RADS score v.2 in predicting malignancy in patients undergoing 5α-reductase inhibitor therapy.
Forte V; Cavallo AU; Bertolo R; de Soccio V; Sperandio M; Bove P; Ciccariello M
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):150-155. PubMed ID: 32681155
[TBL] [Abstract][Full Text] [Related]
14. Increasing prostate-specific antigen levels differently influence prostate cancer detection rates of two different 12-core prostate biopsy schemes.
Lodeta B; Benko G; Trkulja V
Urol Int; 2013; 91(1):75-80. PubMed ID: 23614932
[TBL] [Abstract][Full Text] [Related]
15. Transrectal ultrasound-guided transperineal 14-core systematic biopsy detects apico-anterior cancer foci of T1c prostate cancer.
Kawakami S; Kihara K; Fujii Y; Masuda H; Kobayashi T; Kageyama Y
Int J Urol; 2004 Aug; 11(8):613-8. PubMed ID: 15285751
[TBL] [Abstract][Full Text] [Related]
16. Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the Combination of Avodart and Tamsulosin trial.
Roehrborn CG; Andriole GL; Wilson TH; Castro R; Rittmaster RS
Eur Urol; 2011 Feb; 59(2):244-9. PubMed ID: 21093145
[TBL] [Abstract][Full Text] [Related]
17. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
[TBL] [Abstract][Full Text] [Related]
18. [CLINICOPATHOLOGICAL STUDY OF PROSTATE BIOPSY IN PATIENTS RECEIVING DUTASTERIDE FOR BENIGN PROSTATIC HYPERPLASIA].
Endo T; Kamiya N; Yano M; Oka R; Lee FC; Utsumi T; Kamijima S; Nishimi D; Takanami M; Hiruta N; Suzuki H
Nihon Hinyokika Gakkai Zasshi; 2015 Jul; 106(3):156-62. PubMed ID: 26419072
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
Sciarra A; Panebianco V; Cattarino S; Busetto GM; De Berardinis E; Ciccariello M; Gentile V; Salciccia S
BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of prostate biopsy in patients under the dutasteride treatment.
Obinata D; Nakahara K; Yoshizawa T; Mochida J; Yamaguchi K; Takahashi S
Medicine (Baltimore); 2022 Nov; 101(44):e31658. PubMed ID: 36343082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
